Category - New Drugs
FDA Approves Krintafel (tafenoquine) for the Radical Cure of Plasmodium vivax Malaria
FDA Approves Nivestym (filgrastim-aafi), a Biosimilar to Neupogen
FDA Approves Tibsovo (ivosidenib) for Relapsed or Refractory Acute Myeloid Leukemia with an IDH1 Mutation
Kisqali (ribociclib) Approved for Additional Indications in HR+/HER2- Advanced Breast Cancer
FDA Approves Symtuza (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
FDA Approves TPOXX (tecovirimat) as the First Drug for the Treatment of Smallpox
FDA Approves Xtandi (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) Combination Approved for Previously Treated MSI-H/dMMR Metastatic Colorectal Cancer